Pharmacokinetic The pharmacokinetic shows a low within-dose group variation with dose proportionality for the maximum concentration (Cmax) and at the end of each dosing interval (AUC tau) at steady state for the dose range tested (0.6 mg to 9.0 mg)
Although melasma is a multifactorial skin disorder, however, sun-exposure and genetic predisposition are considered as the main etiologic factors in melasma occurrence
however, several challenges still remain, especially the higher cost of a combined therapy and the worldwide underuse of either GLP-1RAs or SGLT2is in clinical practice, even in patients at high cardiorenal risk
However, it is also recognized that levels of this antioxidant normally decline as we age
The moment you choose the number your skin needs, you take the first step toward clearer, healthier skin
40th Congress of the International Society of Oncology and Biomarkers, October 13-17, 2012